GLP-1 Receptor Agonists: Mechanisms of Action and Class Overview Mechanism of Action: GLP-1 receptor agonists (incretin mimetics) work by mimicking the action of endogenous GLP-1, a gut hormone (incretin) that is released in response to nutrient intake
Drug repurposing: a promising tool to accelerate the drug discovery process
Research indicates particular efficacy for attention-related tasks, with subjects showing enhanced focus duration and reduced distractibility
178 ZhengF.YanL.ZhongB.YangZ.XieW
And churn is a brand problem, not a pricing problem
Tirzepatide tends to be the better fit when: the goal is more significant weight loss (15 percent or more of body weight), the patient has type 2 diabetes with A1C above target on prior therapies, prior single-pathway GLP-1 use produced limited results, or the patient tolerated GLP-1s reasonably well and wants a stronger next step